Announcements Trials
Browse Landscape

Phase

Phase NA 35Phase 2 5Phase EARLY_PHASE1 2Phase 4 2Phase 3 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1

Interventions

Cisplatin 30Magnetic Resonance Spectroscopy 23Carboplatin 23pembrolizumab 21Paclitaxel 20Gemcitabine 19Specimen Handling 16Drug Therapy 15Dexamethasone 15Radiotherapy 14Nivolumab 14Doxorubicin 14Bevacizumab 14atezolizumab 13Oxaliplatin 13Cyclophosphamide 13Radiation 11Pemetrexed 11Cytarabine 11Vincristine 10Prednisone 10Docetaxel 10Capecitabine 10venetoclax 9Trastuzumab 9Temozolomide 8Rituximab 8Platinum 8Ipilimumab 8Fluorouracil 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Control Groups × 1 year × Clear all
NCT07505472 2026-04-01

STARS-RC10

The First Hospital of Jilin University

Phase 2/3 Recruiting
212 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡